Research and Markets has announced the addition of the "Phase II/III Study Trends and Market Outlook (2016-2020)" report to their offering.

For this report, 112 Phase II/III decision-makers were surveyed to gather their insights into where the Phase II/III market is expected to head over the next four years. This report is designed to assist those interested in the Phase II/III market in not only remaining current with market happenings but in getting a jump on what the market is expected to look like in 2020.

What You Will Learn:

- 4-year examination of the industry's Phase II/III market dynamics (i.e. study volume, outsourced spend)

- Average dollar value of outsourced Phase II/III studies and how this varies by sponsor size

- Criteria sponsors use to select (and disqualify) clinical service providers

- Current and future use of adaptive trials and risk-based monitoring in Phase II/III trials

How you can use this report:

- Gain understanding of the key decision-makers within sponsor organizations to develop more targeted communications

- Learn the most desirable characteristics of a Phase II/III service provider

- Discover the expansion into developing markets

Key Topics Covered:

1. Introduction

2. Methodology

3. Respondent Demographics & Qualifications

4. Study Data

Respondent Demographics

- Company Type

- Areas Of Responsibility

- Drug Development Responsibilities

- Respondent Location

- Job Title

- Recent Outsourcing Involvement

- Drug Development Involvement

- Drug Development Involvement By Phase

For more information about this report visit http://www.researchandmarkets.com/research/36svsg/phase_iiiii